Premier Fund Managers Ltd
- SEC CIK
- 0001673907
- Latest filing
- Jul 22, 2026
PCRX holding history
Pacira BioSciences, Inc. in every 13F filed by Premier Fund Managers Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −6,769−100.0% | Sold out | Holders |
| Q2 2024 | 6,769 | $189.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 6,769 | $197.0K | <0.1% | −117,764−94.6% | Reduced | Holders |
| Q4 2023 | 124,533 | $4.18M | 0.2% | −3,310−2.6% | Reduced | Holders |
| Q3 2023 | 127,843 | $3.94M | 0.2% | −23,434−15.5% | Reduced | Holders |
| Q2 2023 | 151,277 | $5.98M | 0.2% | +151,277 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −46,971−100.0% | Sold out | Holders |
| Q4 2022 | 46,971 | $1.83M | 0.1% | +23,721+102.0% | Added | Holders |
| Q3 2022 | 23,250 | $1.26M | 0.1% | −141,000−85.8% | Reduced | Holders |
| Q2 2022 | 164,250 | $9.63M | 0.4% | −36,893−18.3% | Reduced | Holders |
| Q1 2022 | 201,143 | $15.2M | 0.5% | +25,450+14.5% | Added | Holders |
| Q4 2021 | 175,693 | $10.7M | 0.3% | −1,800−1.0% | Reduced | Holders |
| Q3 2021 | 177,493 | $10.1M | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2021 | 177,493 | $10.8M | 0.4% | +3,800+2.2% | Added | Holders |
| Q1 2021 | 173,693 | $12.3M | 0.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.